Gynecological devices are used for treatment of pre-cancerous conditions of the cervix, cysts, genital warts, endometriosis and fibroid tumor disease. Lasers and energy-based devices are used for treatment of obstetric and gynecological conditions. The endometrial ablation devices are used to remove unnecessarily grown body tissue. Digital imaging systems include MRI scans, ultrasound scan, CT scan, mammography, and others.
Moreover, gynecological examination chairs makes conditional screening less cumbersome for the gynecologist. Such innovative devices have augmented the gynecological devices market growth. Growing incidence of gynecological conditions such vaginitis, endometriosis, and uterine fibroids are expected to generate demand for gynecological devices in hospitals and surgical centers. Cervical cancer is one of the most prevalent conditions among women worldwide.
The gynecological devices market size was valued at US$ 8,864 million in 2018 and is expected to witness a CAGR of 8.0% over the forecast period (2019 – 2027).
Global Gynecological Devices Market (%) Analysis, By Surgical Device Type, 2019
Source: Coherent Market Insights Analysis (2019)
Growing gynecological procedures and disorders are expected to drive growth of the Gynecological Devices Market
According to the Endometriosis UK, 10% of the female population was affected by endometriosis in 2016. Moreover, Pelvic Inflammatory Disease (PID) is the second most common and serious complication among women in the U.S. For instance, according to American College of Obstetricians and Gynecologists 2019 report, PID is diagnosed in more than 1 million women each year in the U.S. Furthermore, it increases the risk of cervical cancer, uterine fibroids, and vaginitis. Surgeries are essential in complex gynecological indications. As a result of increasing number of critical and complex surgical procedures, demand for advance gynecological devices is expected to increase during the forecast period.
Global Gynecological Devices Market - Restraints
Stringent rules and regulations associated with approval of products is expected to hamper growth of the global gynecological devices market over the forecast period. For instance, in 2018, energy based device radiofrequency or laser that have received FDA clearance for general gynecologic indications, but not limited to, the destruction of abnormal or pre-cancerous cervical or vaginal tissue and condylomas (genital warts).
Global Gynecological Devices Market - Regional Insights
On the basis of region, the global gynecological devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global gynecological devices market during the forecast period, owing to rising prevalence of sexually transmitted diseases in the U.S. For instance, according to the Centre for Disease Control and Prevention (CDC) 2017, around 45% of the patients in the U.S. with Chlamydia, a sexually transmitted disease, were in the age group of 20 and 24, in 2016.
The market in Asia Pacific is expected to gain momentum during the forecast period, owing to increasing initiatives by regional governments towards gynecological disorders. For instance, Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) initiated by the Ministry of Health and Family Welfare of India in 2016 is focused on reduction of maternal and infant mortality rates through safe pregnancies and deliveries. This programme supports around 30million pregnant women across the India by providing special, free antenatal care. The main aim of the programme is to detect and prevent high-risk pregnancies.
Global Gynecological Devices Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Source: Coherent Market Insights Analysis (2019)
Global Gynecological Devices Market - Competitive Landscape
Key players operating in the gynecological devices market include Ethicon, Inc., Hologic, Inc., MedGyn Product Inc., Stryker Corporation, Cooper Surgical, Inc., Karl Storz GmbH& Co. KG, Boston Scientific Corporation, Richard Wolf GmbH, Medtronic, and Olympus Corporation.
Gynecological devices include devices such as diagnostic imaging devices, surgical devices, sterilization and other devices for diagnosis and treatment of various disease among women. Most of the women worldwide are oblivious to the high risk of dreadful diseases such as cervical cancer, pelvic pain, uterine fibroids, and vaginitis. The Centers for Disease Control and Prevention (CDC) runs a National Breast and Cervical Cancer Early Detection Program (NBCCEDP) that aims to create awareness and provide women in the low-income groups with regular breast and cervical cancer screening and diagnostic services. Early detection is vital in treating such diseases, and such initiatives are expected to propel growth of the gynecological devices market. Additionally, increasing prevalence of gynecological diseases is expected to drive demand for gynecological surgical devices.
Increasing prevalence of cervical cancer worldwide is expected to boost the global gynecological devices market growth. For instance, according to the World Health Organization (WHO), 2018, cervical cancer is the fourth most frequent cancer in women with an estimated 570,000 new cases, representing 6.6% of all cancers occurring in female worldwide, and around 85% of deaths occur due to cervical cancer in emerging economies.
Growth of the gynecology devices market is expected to be hampered over the forecast period, owing to increasing product recalls. For instance in April 2019, the U.S. food and drug administration recalled Medtronic Plc.’s Covidien Endo Grasp, a grasper 5 mm instrument used for a variety of gynecologic procedures, under class 2 device recall as the sterilization method used was not consistent with the labelling and the approved sterilization method.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.